Analysts expect Abeona Therapeutics Inc. to report revenue of 14.21 M for Q3 26, against a range of 13.63 M to 14.79 M. The most recent reported quarter, Q2 26, came in at 11.38 M, a 11.3% miss against the 12.84 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 400,000.00 | 0.00 | 5.40 M | 8.72 M | 11.38 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 113,377.69 | 109,840.51 | 0.00 | 0.00 | 5.50 M | 4.61 M | 4.43 M | 13.33 M | 14.79 M | 18.78 M | 20.91 M | 28.28 M | 37.59 M | 37.75 M | 43.32 M | 46.81 M | ||||||||||
| Low Estimate | 100,192.31 | 98,777.49 | 0.00 | 0.00 | 5.11 M | 4.00 M | 4.12 M | 12.34 M | 13.63 M | 17.62 M | 18.15 M | 26.46 M | 30.78 M | 34.88 M | 39.26 M | 39.37 M | ||||||||||
| Consensus Estimate | 106,785.00 | 104,309.00 | 0.00 | 0.00 | 5.30 M | 4.30 M | 4.28 M | 12.84 M | 14.21 M | 18.20 M | 19.53 M | 27.37 M | 34.19 M | 36.31 M | 41.29 M | 43.09 M |
Analysts expect Abeona Therapeutics Inc. to report earnings per share of -0.18 for Q3 26, against a range of -0.20 to -0.16. The most recent reported quarter, Q2 26, came in at -0.35, a 59.1% miss against the -0.22 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.63 | 0.50 | -0.24 | 1.71 | -0.10 | -0.36 | -0.30 | -0.35 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.35 | -0.30 | -0.36 | -0.37 | -0.24 | -0.33 | -0.31 | -0.20 | -0.16 | -0.11 | -0.12 | -0.06 | -0.10 | -0.12 | 0.07 | 0.28 | ||||||||||
| Low Estimate | -0.43 | -0.36 | -0.40 | -0.43 | -0.28 | -0.39 | -0.33 | -0.24 | -0.20 | -0.13 | -0.14 | -0.06 | -0.12 | -0.14 | 0.07 | 0.24 | ||||||||||
| Consensus Estimate | -0.39 | -0.33 | -0.38 | -0.40 | -0.26 | -0.36 | -0.32 | -0.22 | -0.18 | -0.12 | -0.13 | -0.06 | -0.11 | -0.13 | 0.07 | 0.26 |
Pull Wall Street consensus for Abeona Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ABEO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ABEO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ABEO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();